A detailed history of Harel Insurance Investments & Financial Services Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Harel Insurance Investments & Financial Services Ltd. holds 584 shares of GILD stock, worth $49,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares
584
Previous 641 8.89%
Holding current value
$49,026
Previous $47,000 14.89%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$63.15 - $72.88 $3,599 - $4,154
-57 Reduced 8.89%
584 $40,000
Q4 2023

Jan 30, 2024

SELL
$73.27 - $83.09 $219 - $249
-3 Reduced 0.47%
641 $52,000
Q3 2023

Oct 30, 2023

SELL
$73.94 - $80.67 $1.3 Million - $1.42 Million
-17,634 Reduced 96.48%
644 $48,000
Q2 2023

Jul 17, 2023

SELL
$76.01 - $86.7 $1.09 Million - $1.25 Million
-14,402 Reduced 44.07%
18,278 $1.39 Million
Q1 2023

May 02, 2023

BUY
$77.31 - $88.08 $320,681 - $365,355
4,148 Added 14.54%
32,680 $2.66 Million
Q4 2022

Jan 26, 2023

BUY
$62.32 - $89.47 $456,930 - $655,994
7,332 Added 34.58%
28,532 $2.43 Million
Q3 2022

Oct 31, 2022

BUY
$59.54 - $68.01 $119,080 - $136,020
2,000 Added 10.42%
21,200 $1.34 Million
Q2 2022

Jul 19, 2022

BUY
$57.72 - $65.01 $1.1 Million - $1.24 Million
19,020 Added 10566.67%
19,200 $1.19 Million
Q1 2022

May 03, 2022

BUY
$57.92 - $72.58 $5,502 - $6,895
95 Added 111.76%
180 $11,000
Q4 2021

Feb 07, 2022

SELL
$64.88 - $73.64 $345,356 - $391,985
-5,323 Reduced 98.43%
85 $6,000
Q3 2021

Oct 25, 2021

BUY
$67.69 - $73.03 $172,067 - $185,642
2,542 Added 88.7%
5,408 $378,000
Q2 2021

Jul 26, 2021

SELL
$63.47 - $69.35 $82,384 - $90,016
-1,298 Reduced 31.17%
2,866 $643,000
Q1 2021

Apr 27, 2021

SELL
$60.0 - $68.46 $275,580 - $314,436
-4,593 Reduced 52.45%
4,164 $899,000
Q4 2020

Jan 26, 2021

SELL
$56.65 - $64.55 $452,803 - $515,948
-7,993 Reduced 47.72%
8,757 $1.64 Million
Q3 2020

Oct 20, 2020

BUY
$62.1 - $78.08 $965,406 - $1.21 Million
15,546 Added 1291.2%
16,750 $1.06 Million
Q2 2020

Jul 14, 2020

SELL
$72.34 - $84.0 $647,153 - $751,464
-8,946 Reduced 88.14%
1,204 $93,000
Q1 2020

Apr 28, 2020

BUY
$62.63 - $80.22 $632,938 - $810,703
10,106 Added 22968.18%
10,150 $759,000
Q4 2019

Jan 23, 2020

SELL
$61.62 - $67.78 $447,114 - $491,811
-7,256 Reduced 99.4%
44 $3,000
Q3 2019

Nov 06, 2019

BUY
$62.51 - $69.0 $181,279 - $200,100
2,900 Added 65.91%
7,300 $463,000
Q2 2019

Jul 22, 2019

BUY
$61.87 - $69.38 $74,244 - $83,256
1,200 Added 37.5%
4,400 $297,000
Q1 2019

Apr 18, 2019

SELL
$62.53 - $70.05 $50,899 - $57,020
-814 Reduced 20.28%
3,200 $208,000
Q4 2018

Jan 29, 2019

SELL
$60.54 - $79.0 $128,405 - $167,559
-2,121 Reduced 34.57%
4,014 $251,000
Q3 2018

Oct 29, 2018

SELL
$71.28 - $78.92 $560,617 - $620,705
-7,865 Reduced 56.18%
6,135 $474,000
Q2 2018

Jul 30, 2018

BUY
$64.88 - $75.68 $129,759 - $151,360
2,000 Added 16.67%
14,000 $992,000
Q1 2018

Apr 30, 2018

BUY
$72.84 - $88.8 $506,383 - $617,337
6,952 Added 137.72%
12,000 $905,000
Q4 2017

Feb 01, 2018

BUY
$71.15 - $83.52 $1,992 - $2,338
28 Added 0.56%
5,048 $362,000
Q3 2017

Nov 02, 2017

BUY
$72.11 - $85.47 $361,992 - $429,059
5,020
5,020 $407,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $105B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.